Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial
Zhijian Luo, Wei Chen, Mingqing Xiang, et al.
European Journal of Integrative Medicine (2021) Vol. 42, pp. 101305-101305
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Traditional Chinese medicine against COVID-19: Role of the gut microbiota
Zhihua Yang, Yangxi Liu, Lin Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112787-112787
Open Access | Times Cited: 44
Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
Ling Ye, Shicheng Fan, Pengfei Zhao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3598-3637
Open Access | Times Cited: 28
Role of herbal medicines in the management of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Ansul Kumar, Arpita Rai, Mohd Saif Khan, et al.
Journal of Traditional and Complementary Medicine (2022) Vol. 12, Iss. 1, pp. 100-113
Open Access | Times Cited: 36
Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
Heping Wang, Bowen Xu, Ying Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 40
Current status of traditional Chinese medicine for the treatment of COVID-19 in China
Liang Chu, Fang Huang, Mengdan Zhang, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 38
Effectiveness and Safety of Traditional Chinese Medicine in Treating COVID-19: Clinical Evidence from China
Dongmei Xing, Zhibin Liu
Aging and Disease (2021) Vol. 12, Iss. 8, pp. 1850-1850
Open Access | Times Cited: 33
Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 Treatment
Ke-Yao Xia, Zeyuan Zhao, Taif Shah, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
Progress in Traditional Chinese Medicine Against Respiratory Viruses: A Review
B. Li, Zhongyuan Li, Miao Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 31
The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19
Takahiro Itaya, Yotsuha Isobe, Sayoko Suzuki, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e222973-e222973
Open Access | Times Cited: 22
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review
Ling‐Ying Lu, Po‐Hao Feng, Ming‐Sun Yu, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 63, pp. 34-43
Open Access | Times Cited: 20
Do Diet and Dietary Supplements Mitigate Clinical Outcomes in COVID-19?
Bhavdeep Singh, Eli Eshaghian, Judith Chuang, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1909-1909
Open Access | Times Cited: 19
Traditional Chinese Medicines Against COVID-19
Chang-Liang Yao, Wenlong Wei, Jian-Qing Zhang, et al.
World Journal of Traditional Chinese Medicine (2022) Vol. 8, Iss. 3, pp. 279-313
Open Access | Times Cited: 19
Antiviral Treatment Options for Severe Fever with Thrombocytopenia Syndrome Infections
Yin Zhang, Ying Huang, Yuanhong Xu
Infectious Diseases and Therapy (2022) Vol. 11, Iss. 5, pp. 1805-1819
Open Access | Times Cited: 19
The role and advantage of traditional Chinese medicine in the prevention and treatment of COVID-19
Ming Huang, Yao-Yuan Liu, Ke Xiong, et al.
Journal of Integrative Medicine (2023) Vol. 21, Iss. 5, pp. 407-412
Closed Access | Times Cited: 12
Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets
Zhouman He, Jia Yuan, Yuanwen Zhang, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1186-1210
Open Access | Times Cited: 11
Effect of Chinese herbal medicine (CHM) as an adjunctive therapy in distinct stages of patients with COVID-19: A systematic review and meta-analysis
Jin-Min Gu, Shu-Nan Zhang, Si-Yao Xiao, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318892-e0318892
Open Access
The efficacy of different traditional Chinese medicine treatment for Corona Virus Disease 2019: Systematic Review and Meta-analysis
S U Youzhu, Rui Su, Shuo Wang, et al.
Journal of Herbal Medicine (2025), pp. 101001-101001
Open Access
Comprehensive integration of diagnostic biomarker analysis and immune cell infiltration features in sepsis via machine learning and bioinformatics techniques
Liuqing Yang, Rui Xuan, Dawei Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Evaluating the Efficacy of Traditional Chinese Medicine in Treating COVID-19 and Long-COVID Symptoms: A Combined Meta-Analysis and Retrospective Study
Jennifer Cruz, Yan D. Zhao, Yuanhua Wang, et al.
Journal of Herbal Medicine (2025), pp. 101012-101012
Closed Access
The methodological reporting quality in strictly randomized controlled trials for COVID-19 and precise reporting of Chinese herbal medicine formula intervention
Min‐Li Chen, Shi-Yan Qian, Jiang-Li Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Research Progress in Chinese Herbal Medicines for Treatment of Sepsis: Pharmacological Action, Phytochemistry, and Pharmacokinetics
Chen Cheng, Xuan Yu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11078-11078
Open Access | Times Cited: 25
Methyl rosmarinate is an allosteric inhibitor of SARS-cov-2 3 C L protease as a potential candidate against SARS-cov-2 infection
Hongtao Li, Meng Sun, Fuzhi Lei, et al.
Antiviral Research (2024) Vol. 224, pp. 105841-105841
Closed Access | Times Cited: 3
Cytokine Storm in COVID-19: Insight into Pathological Mechanisms and Therapeutic Benefits of Chinese Herbal Medicines
Qingyuan Yu, Xian Zhou, Rotina Kapini, et al.
Medicines (2024) Vol. 11, Iss. 7, pp. 14-14
Open Access | Times Cited: 3
Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines
Ying Wu, Ping Zhong
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies
Mengting Li, Hongfei Zhu, Yafei Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top